1. Home
  2. NAII vs PASG Comparison

NAII vs PASG Comparison

Compare NAII & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Alternatives International Inc.

NAII

Natural Alternatives International Inc.

N/A

Current Price

$1.09

Market Cap

15.8M

Sector

Health Care

ML Signal

N/A

Logo Passage Bio Inc.

PASG

Passage Bio Inc.

N/A

Current Price

$3.90

Market Cap

12.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NAII
PASG
Founded
1980
2017
Country
United States
United States
Employees
N/A
24
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.8M
12.8M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
NAII
PASG
Price
$1.09
$3.90
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $15.50
AVG Volume (30 Days)
★ 22.8K
13.8K
Earning Date
11-20-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $132,437,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 8.60
N/A
52 Week Low
$1.06
$3.29
52 Week High
$4.96
$20.00

Technical Indicators

Market Signals
Indicator
NAII
PASG
Relative Strength Index (RSI) 33.24 54.57
Support Level $1.08 $3.30
Resistance Level $2.52 $5.03
Average True Range (ATR) 0.05 0.24
MACD 0.02 0.07
Stochastic Oscillator 24.55 98.36

Price Performance

Historical Comparison
NAII
PASG

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products, to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segments. The company derives the majority of revenue from Private-Label Contract Manufacturing, which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

Share on Social Networks: